{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:31:09Z","timestamp":1789425069279,"version":"build-2803163510"},"reference-count":112,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T00:00:00Z","timestamp":1595808000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Biomedicines"],"abstract":"<jats:p>Radiotherapy is one of the treatments of choice in many types of cancer. Adjuvant treatments to radiotherapy try, on one hand, to enhance the response of tumor cells to radiation and, on the other hand, to reduce the side effects to normal cells. Radiosensitizers are agents that increase the effect of radiation in tumor cells by trying not to increase side effects in normal tissues. Melatonin is a hormone produced mainly by the pineal gland which has an important role in the regulation of cancer growth, especially in hormone-dependent mammary tumors. Different studies have showed that melatonin administered with radiotherapy is able to enhance its therapeutic effects and can protect normal cells against side effects of this treatment. Several mechanisms are involved in the radiosensitization induced by melatonin: increase of reactive oxygen species production, modulation of proteins involved in estrogen biosynthesis, impairment of tumor cells to DNA repair, modulation of angiogenesis, abolition of inflammation, induction of apoptosis, stimulation of preadipocytes differentiation and modulation of metabolism. At this moment, there are very few clinical trials that study the therapeutic usefulness to associate melatonin and radiotherapy in humans. All findings point to melatonin as an effective adjuvant molecule to radiotherapy in cancer treatment.<\/jats:p>","DOI":"10.3390\/biomedicines8080247","type":"journal-article","created":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T04:39:50Z","timestamp":1595824790000},"page":"247","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":25,"title":["Melatonin as a Radio-Sensitizer in Cancer"],"prefix":"10.3390","volume":"8","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3049-1408","authenticated-orcid":false,"given":"Carolina","family":"Alonso-Gonz\u00e1lez","sequence":"first","affiliation":[{"name":"Department of Physiology and Pharmacology, School of Medicine, University of Cantabria and Instituto de Investigaci\u00f3n Sanitaria Valdecilla (IDIVAL), 39011 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Gonz\u00e1lez","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology, School of Medicine, University of Cantabria and Instituto de Investigaci\u00f3n Sanitaria Valdecilla (IDIVAL), 39011 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6710-6457","authenticated-orcid":false,"given":"Javier","family":"Men\u00e9ndez-Men\u00e9ndez","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology, School of Medicine, University of Cantabria and Instituto de Investigaci\u00f3n Sanitaria Valdecilla (IDIVAL), 39011 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8926-5977","authenticated-orcid":false,"given":"Carlos","family":"Mart\u00ednez-Campa","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology, School of Medicine, University of Cantabria and Instituto de Investigaci\u00f3n Sanitaria Valdecilla (IDIVAL), 39011 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Cos","sequence":"additional","affiliation":[{"name":"Department of Physiology and Pharmacology, School of Medicine, University of Cantabria and Instituto de Investigaci\u00f3n Sanitaria Valdecilla (IDIVAL), 39011 Santander, Spain"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,7,27]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.prro.2015.02.012","article-title":"Definitive radiation therapy in locally advanced non small cell lung cancer: Executive summary of an American Society for Radiation Oncology (ASTRO) evidence-based clinical practice guideline","volume":"5","author":"Rodrigues","year":"2015","journal-title":"Pract. Radiat. Oncol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.prro.2014.01.003","article-title":"The role of postoperative radiation therapy for endometrial cancer: Executive summary of an American Society for Radiation Oncology evidence-based guideline","volume":"4","author":"Klopp","year":"2014","journal-title":"Pract. Radiat. Oncol."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/j.ijrobp.2013.05.029","article-title":"Adjuvant and salvage radiation therapy after prostatectomy: American Society for Radiation Oncology\/American Urological Association guidelines","volume":"86","author":"Valicenti","year":"2013","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1269\/jrr.42.21","article-title":"Radioprotectors in radiotherapy","volume":"42","author":"Nair","year":"2001","journal-title":"J. Radiat. Res."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1582-4934.2001.tb00158.x","article-title":"New concepts in radiation-induced apoptosis: \u2018premitotic apoptosis\u2019 and \u2018postmitotic Apoptosis\u2019","volume":"5","author":"Shinomiya","year":"2001","journal-title":"J. Cell Mol. Med."},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Coliat, P., Ramolu, L., J\u00e9gu, J., Gaiddon, C., Jung, A.C., and Pencreach, E. (2019). Constitutive or induced HIF-2 addiction is involved in resistance to anti-EGFR treatment and radiation therapy in HNSCC. Cancers, 11.","DOI":"10.3390\/cancers11101607"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"34755","DOI":"10.1021\/acsami.9b12879","article-title":"Janus gold triangle-mesoporous silica nanoplatforms for hypoxia-activated radio-chemo-phototermal therapy of liver cancer","volume":"11","author":"Wang","year":"2019","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1021\/acs.jmedchem.7b01678","article-title":"Next-generation hypoxic cell radiosensitizers: Nitroimidazole alkylsulfonamides","volume":"61","author":"Bonnet","year":"2018","journal-title":"J. Med. Chem."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1002\/ijc.32227","article-title":"Inhibition of HSP90 overcomes resistance to chemotherapy and radiotherapy in pancreatic cancer","volume":"145","author":"Nagaraju","year":"2019","journal-title":"Int. J. Cancer"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1016\/j.ymthe.2019.07.011","article-title":"Hypoxic glioma cell-secreted exosomal miR-301a activates Wnt\/\u03b2 -catenin signaling and promotes radiation resistance by targeting TCEAL7","volume":"27","author":"Yue","year":"2019","journal-title":"Mol. Ther."},{"key":"ref_11","unstructured":"Hall, E.J., and Giaccia, A.J. (2012). Radiobiology for the Radiologist, LippincottWilliams & Wilkins. [7th ed.]."},{"key":"ref_12","first-page":"9","article-title":"Radiation-induced inflammation and autoimmune diseases","volume":"5","author":"Yahyapour","year":"2018","journal-title":"Mil. Med. Res."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/1874471011666171229123130","article-title":"Mechanisms of radiation bystander and non-targeted effects: Implications to radiation carcinogenesis and radiotherapy","volume":"11","author":"Yahyapour","year":"2018","journal-title":"Curr. Radiopharm."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/s12094-017-1828-6","article-title":"Reduction-oxidation (redox) system in radiation-induced normal tissue injury: Molecular mechanisms and implications in radiation therapeutics","volume":"20","author":"Yahyapour","year":"2018","journal-title":"Clin. Transl. Oncol."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.dnarep.2004.03.006","article-title":"Mammalian cell cycle checkpoints: Signalling pathways and their organization in space and time","volume":"3","author":"Lukas","year":"2004","journal-title":"DNA Repair"},{"key":"ref_16","doi-asserted-by":"crossref","unstructured":"Maier, P., Hartmann, L., Wenz, F., and Herskind, C. (2016). Cellular pathways in response to ionizing radiation and their targetability for tumorradiosensitization. Int. J. Mol. Sci., 17.","DOI":"10.3390\/ijms17010102"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1146\/annurev.biochem.77.061306.125255","article-title":"Mechanism of eukaryotic homologous recombination","volume":"77","author":"Sung","year":"2008","journal-title":"Annu. Rev. Biochem."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.semradonc.2005.08.007","article-title":"Radiation and new molecular agents part 1: Targeting ATM-ATR checkpoints, DNA repair and the proteasome","volume":"16","author":"Choudhury","year":"2006","journal-title":"Semin. Radiat. Oncol."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"5706","DOI":"10.1128\/MCB.23.16.5706-5715.2003","article-title":"Pathways of DNA double-strand break repair during the mammalian cell cycle","volume":"23","author":"Rothkamm","year":"2003","journal-title":"Mol. Cell Biol."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1074\/jbc.R700039200","article-title":"The mechanism of human nonhomologous DNA end joining","volume":"283","author":"Lieber","year":"2008","journal-title":"J. Biol. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.dnarep.2014.02.020","article-title":"DNA-PK: A dynamic enzyme in a versatile DSB repair pathway","volume":"17","author":"Davis","year":"2014","journal-title":"DNA Repair"},{"key":"ref_22","first-page":"6008","article-title":"Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1","volume":"63","author":"Veuger","year":"2003","journal-title":"Cancer Res."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0304-4165(98)00020-8","article-title":"Increased expression of the DNA-dependent protein kinase confers resistance to Adriamycin","volume":"1381","author":"Shen","year":"1998","journal-title":"Biochim. Biophys. Acta"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0169-5002(03)00026-6","article-title":"DNA repair rate and etoposide (VP16) resistance of tumour cell subpopulations derived from a single human small cell lung cancer","volume":"40","author":"Hansen","year":"2003","journal-title":"Lung Cancer"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1667\/RR2663.1","article-title":"Effects of radiation quality and oxygen on clustered DNA lesions and cell death","volume":"176","author":"Stewart","year":"2011","journal-title":"Radiat. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.4161\/auto.5.8.9896","article-title":"Autophagy, senescence and tumor dormancy in cancer therapy","volume":"5","author":"Gewirtz","year":"2009","journal-title":"Autophagy"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"4079","DOI":"10.1007\/s13277-015-3496-x","article-title":"Autophagy and its function in radiosensitivity","volume":"36","author":"Yang","year":"2015","journal-title":"Tumor Biol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1124\/jpet.112.197590","article-title":"The autophagy-senescence connection in chemotherapy: Must tumor cells (self) eat before they sleep?","volume":"343","author":"Goehe","year":"2012","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1055\/s-0038-1626525","article-title":"Membrane receptor signalling and control of DNA repair after exposure to ionizing radiation","volume":"49","author":"Toulany","year":"2010","journal-title":"Nuklearmedizin"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"4654","DOI":"10.1038\/sj.onc.1202835","article-title":"Inhibition of pp60c-Src reduces BCL-XL expression and reverses the transformed phenotype of cells overexpressing EGF and HER-2 receptors","volume":"18","author":"Karni","year":"1999","journal-title":"Oncogene"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1021\/jz401358w","article-title":"How to find out whether a 5-substituted uracil could be a potential radiosensitizer","volume":"4","author":"Chomicz","year":"2013","journal-title":"J. Phys. Chem. Lett."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"8227","DOI":"10.1021\/acs.jpcb.5b03948","article-title":"Mechanisms of damage to DNA labeled with electrophilic nucleobases induced by ionizing radiation or UV radiation","volume":"119","author":"Rak","year":"2015","journal-title":"J. Phys. Chem. B"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.tips.2017.11.003","article-title":"Cancer Radiosensitizers","volume":"39","author":"Wang","year":"2018","journal-title":"Trends Pharmacol. Sci."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.molmed.2014.07.004","article-title":"miRNAs in tumor radiation response: Bystanders or participants?","volume":"20","author":"Gandellini","year":"2014","journal-title":"Trends Mol. Med."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1016\/j.ijrobp.2016.10.011","article-title":"Subgroup analysis according to human papillomavirus status and tumor site of a randomized phase II trial comparing cetuximab and cisplatin combined with radiation therapy for locally advanced head and neck cancer","volume":"97","author":"Buglione","year":"2017","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"15130","DOI":"10.1038\/ncomms15130","article-title":"Gold nanoclusters-assisted delivery of NGF siRNA for effective treatment of pancreatic cancer","volume":"8","author":"Lei","year":"2017","journal-title":"Nat. Commun."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1006\/frne.1999.0194","article-title":"Melatonin and mammary pathological growth","volume":"21","author":"Cos","year":"2000","journal-title":"Front. Neuroendocrinol."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1530\/ERC-15-0030","article-title":"Melatonin: An inhibitor of breast cancer","volume":"22","author":"Hill","year":"2015","journal-title":"Endocr. Relat. Cancer"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"38294","DOI":"10.1074\/jbc.M403140200","article-title":"Melatonin, an endogenous-specific inhibitor of estrogen receptor alpha via calmodulin","volume":"279","author":"Zuazua","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1210\/edrv-1-2-109","article-title":"The pineal and its hormones in the control of reproduction in mammals","volume":"1","author":"Reiter","year":"1980","journal-title":"Endocr. Rev."},{"key":"ref_41","first-page":"1681","article-title":"Modulation of estrogen receptor mRNA expression by melatonin in MCF-7 human breast cancer cells","volume":"8","author":"Molis","year":"1994","journal-title":"Mol. Endocrinol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1111\/j.1600-079X.1991.tb00007.x","article-title":"Effects of melatonin on the cell cycle kinetics and estrogen rescue of MCF-7 human breast cancer cells in culture","volume":"10","author":"Cos","year":"1991","journal-title":"J. Pineal Res."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000014529","article-title":"Melatonin involvement in immunity and cancer","volume":"7","author":"Fraschini","year":"1998","journal-title":"Biol. Signals Recept."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1034\/j.1600-079X.2003.00077.x","article-title":"Melatonin inhibits telomerase activity in the MCF-7 tumor cell line both in vivo and in vitro","volume":"35","author":"Guerrero","year":"2003","journal-title":"J. Pineal Res."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.canlet.2008.04.001","article-title":"Melatonin down-regulates hTERT expression induced by either natural estrogens (17beta-estradiol) or metalloestrogens (cadmium) in MCF-7 human breast cancer cells","volume":"268","author":"Mediavilla","year":"2008","journal-title":"Cancer Lett."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.3892\/or.2013.2314","article-title":"Melatonin modulates aromatase activity and expression in endothelial cells","volume":"29","author":"Cos","year":"2013","journal-title":"Oncol. Rep."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1111\/jpi.12007","article-title":"Regulation of vascular endothelial growth factor by melatonin in human breast cancer cells","volume":"54","author":"Cos","year":"2013","journal-title":"J. Pineal Res."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.mvr.2013.02.008","article-title":"Antiangiogenic effects of melatonin in endothelial cell cultures","volume":"87","author":"Cos","year":"2013","journal-title":"Microvasc. Res."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1600-079X.2003.02112.x","article-title":"The chemistry of melatonin\u2019s interaction with reactive species","volume":"34","author":"Allegra","year":"2003","journal-title":"J. Pineal Res."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1023\/A:1024030518065","article-title":"Growth and fatty acid metabolism of human breast cancer (MCF-7) xenografts in nude rats: Impact of constant light-induced nocturnal melatonin suppression","volume":"79","author":"Blask","year":"2003","journal-title":"Breast Cancer Res. Treat."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1385\/ENDO:27:2:179","article-title":"Putting cancer to sleep at night","volume":"27","author":"Blask","year":"2005","journal-title":"Endocrine"},{"key":"ref_52","first-page":"7187128","article-title":"Melatonin enhances cisplatin and radiation cytotoxicity in head and neck squamous cell carcinoma by stimulating mitochondrial ROS generation, apoptosis, and autophagy oxidative medicine and cellular longevity","volume":"2019","author":"Shen","year":"2019","journal-title":"Oxid. Med. Cell. Longev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1007\/s10103-016-2016-6","article-title":"Effects of combination of melatonin and laser irradiation on ovarian cancer cells and endothelial lineage viability","volume":"31","author":"Akbarzadeh","year":"2016","journal-title":"Lasers Med. Sci."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1177\/1559325819877271","article-title":"Different effects of melatonin on X-rays-irradiated cancer cells in a dose-dependent manner","volume":"17","author":"Zhu","year":"2019","journal-title":"Dose Response"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/j.redox.2018.02.025","article-title":"Melatonin suppresses thyroid cancer growth and overcomes radioresistance via inhibition of p65 phosphorylation and induction of ROS","volume":"16","author":"Zou","year":"2018","journal-title":"Redox Biol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.canlet.2015.10.015","article-title":"Melatonin enhancement of the radiosensitivity of human breast cancer cells is associated with the modulation of proteins involved in estrogen biosynthesis","volume":"370","author":"Cos","year":"2016","journal-title":"Cancer Lett."},{"key":"ref_57","first-page":"6304","article-title":"Participation of p53 protein in the cellular response to DNA damage","volume":"51","author":"Kastan","year":"1991","journal-title":"Cancer Res."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1158\/0008-5472.CAN-14-2164","article-title":"Prostaglandin E2 inhibits p53 in human breast adipose stromal cells: A novel mechanism for the regulation of aromatase in obesity and breast cancer","volume":"75","author":"Wang","year":"2015","journal-title":"Cancer Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"879","DOI":"10.3389\/fphys.2019.00879","article-title":"Melatonin enhances the usefulness of ionizing radiation: Involving the regulation of different steps of the angiogenic process","volume":"10","author":"Rueda","year":"2019","journal-title":"Front. Physiol."},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Gonz\u00e1lez-Gonz\u00e1lez, A., Garc\u00eda-Nieto, E., Gonz\u00e1lez, A., S\u00e1nchez-Fern\u00e1ndez, C., Alonso-Gonz\u00e1lez, C., Men\u00e9ndez-Men\u00e9ndez, J., G\u00f3mez-Arozamena, J., Cos, S., and Mart\u00ednez-Campa, C. (2019). Melatonin modulation of radiation and chemotherapeutics-induced changes on differentiation of breast fibroblasts. Int. J. Mol. Sci., 20.","DOI":"10.3390\/ijms20163935"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/jpi.12205","article-title":"Melatonin sensitizes human breast cancer cells to ionizing radiation by downregulating proteins involved in double-strand DNA break repair","volume":"58","author":"Cos","year":"2015","journal-title":"J. Pineal Res."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"5792","DOI":"10.1038\/sj.onc.1206679","article-title":"Regulation and mechanisms of mammalian double-strand break repair","volume":"22","author":"Valerie","year":"2003","journal-title":"Oncogene"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1038\/sj.cdd.4401903","article-title":"p53 in recombination and repair","volume":"13","author":"Gatz","year":"2006","journal-title":"Cell Death Differ."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"335","DOI":"10.3109\/01480545.2012.737805","article-title":"The modulatory effect of melatonin on genotoxicity of irinotecan in healthy human lymphocytes and cancer cells","volume":"36","author":"Kontek","year":"2013","journal-title":"Drug Chem. Toxicol."},{"key":"ref_65","doi-asserted-by":"crossref","unstructured":"Wang, Q., Sun, Z., Du, L., Xu, C., Wang, Y., Yang, B., He, N., Wang, J., Ji, K., and Liu, Y. (2018). Melatonin sensitizes human colorectal cancer cells to \u03b3-ray ionizing radiation in vitro and in vivo. Int. J. Mol. Sci., 19.","DOI":"10.3390\/ijms19123974"},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"S1070","DOI":"10.4103\/0973-1482.196758","article-title":"Radioprotective effect of melatonin on expression of Cdkn1a and Rad50 genes in rat peripheral blood","volume":"14","author":"Rezaeejam","year":"2018","journal-title":"J. Cancer Res. Ther."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s12551-017-0256-8","article-title":"The melatonin immunomodulatory actions in radiotherapy","volume":"9","author":"Nagafi","year":"2017","journal-title":"Biophys. Rev."},{"key":"ref_68","doi-asserted-by":"crossref","first-page":"97","DOI":"10.3109\/09553002.2013.734943","article-title":"Melatonin reduces X-ray radiation-induced lung injury in mice by modulating oxidative stress and cytokine expression","volume":"89","author":"Jang","year":"2013","journal-title":"Int. J. Radiat. Biol."},{"key":"ref_69","first-page":"236","article-title":"Melatonin Attenuates Up-regulation of Duox1 and Duox2 and protects against lung injury following chest irradiation in rats","volume":"21","author":"Aliasgharzadeh","year":"2019","journal-title":"Cell J."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.lfs.2019.05.009","article-title":"Modulation of apoptosis by melatonin for improving cancer treatment efficiency: An updated review","volume":"228","author":"Mortezaeea","year":"2019","journal-title":"Life Sci."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.biopha.2016.07.004","article-title":"Melatonin promotes ATO-induced apoptosis in MCF-7 cells: Proposing novel therapeutic potential for breast cancer","volume":"83","author":"Nooshinfar","year":"2016","journal-title":"Biomed. Pharmacother."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/jpi.12060","article-title":"Melatonin overcomes apoptosis resistance in human hepatocellular carcinoma by targeting survivin and XIAP","volume":"55","author":"Fan","year":"2013","journal-title":"J. Pineal Res."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"7059","DOI":"10.1158\/0008-5472.CAN-06-0325","article-title":"Cyclooxygenase-2 inhibition induces apoptosis signaling via death receptors and mitochondria in hepatocellular carcinoma","volume":"66","author":"Kern","year":"2006","journal-title":"Cancer Res."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/jpi.12298","article-title":"Melatonin suppression of aerobic glycolysis (Warburg effect), survival signalling and metastasis in human leiomyosarcoma","volume":"60","author":"Mao","year":"2016","journal-title":"J. Pineal Res."},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"S\u00e1nchez-S\u00e1nchez, A.M., Antolin, I., Puente-Moncada, N., Suarez, S., Gomez-Lobo, M., Rodriguez, C., and Martin, V. (2015). Melatonin cytotoxicity is associated to Warburg effect inhibition in Ewing sarcoma cells. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0135420"},{"key":"ref_76","doi-asserted-by":"crossref","unstructured":"Blask, D.E., Dauchy, R.T., Dauchy, E.M., Mao, L., Hill, S.M., Greene, M.W., Belancio, V.P., Sauer, L.A., and Davidson, L. (2014). Light exposure at night disrupts host\/cancer circadian regulatory dynamics: Impact on the Warburg effect, lipid signaling and tumor growth prevention. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0102776"},{"key":"ref_77","first-page":"473","article-title":"Daytime blue light enhances the nighttime circadian melatonin inhibition of human prostate cancer growth","volume":"65","author":"Dauchy","year":"2015","journal-title":"Comp. Med."},{"key":"ref_78","first-page":"57","article-title":"Melatonin: A potent, endogenous hydroxyl radical scavenger","volume":"1","author":"Tan","year":"1993","journal-title":"Endocr. J."},{"key":"ref_79","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1046\/j.1600-079X.2003.00092.x","article-title":"Regulation of antioxidant enzymes: A significant role for melatonin","volume":"36","author":"Mayo","year":"2004","journal-title":"J. Pineal Res."},{"key":"ref_80","doi-asserted-by":"crossref","unstructured":"Galano, A., Tan, D.X., and Reiter, R.J. (2018). Melatonin: A versatile protector against oxidative DNA damage. Molecules, 23.","DOI":"10.3390\/molecules23030530"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1111\/j.1749-6632.2000.tb05403.x","article-title":"Gene regulation by melatonin","volume":"917","author":"Carlberg","year":"2000","journal-title":"Ann. N. Y. Acad. Sci."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/S0140-6736(78)92591-6","article-title":"Role of pineal gland in aetiology and treatment of breast cancer","volume":"2","author":"Cohen","year":"1978","journal-title":"Lancet"},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1016\/j.cdp.2006.03.002","article-title":"Estrogen-signaling pathway: A link between breast cancer and melatonin oncostatic actions","volume":"30","author":"Cos","year":"2006","journal-title":"Cancer Detect. Prev."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2174\/156800910791190201","article-title":"In Vivo inhibition of the estrogen sulfatase enzyme and growth of DMBA-induced mammary tumors by melatonin","volume":"10","author":"Mediavilla","year":"2010","journal-title":"Curr. Cancer Drug Targets"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3892\/ol.2014.2203","article-title":"Melatonin modulation of crosstalk among malignant epithelial, endothelial and adipose cells in breast cancer","volume":"8","author":"Cos","year":"2014","journal-title":"Oncol. Lett."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1600-079X.2008.00559.x","article-title":"Selective estrogen enzyme modulator (SEEM) actions of melatonin in human breast cancer cells","volume":"45","author":"Cos","year":"2008","journal-title":"J. Pineal Res."},{"key":"ref_87","first-page":"65","article-title":"DNA repair targeted therapy: The past or future of cancer treatment?","volume":"160","author":"Gavande","year":"2016","journal-title":"Pharmacol. Ter."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/jnci\/88.19.1346","article-title":"DNA repair: Enzymatic mechanisms and relevance to drug response","volume":"88","author":"Chaney","year":"1996","journal-title":"J. Natl. Cancer Inst."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/B978-0-12-407676-1.00001-9","article-title":"The repair and signaling responses to DNA double-strand breaks","volume":"82","author":"Goodarzi","year":"2013","journal-title":"Adv. Genet."},{"key":"ref_90","first-page":"219","article-title":"Elevated levels of Rad51 recombination protein in tumor cells","volume":"62","author":"Raderschall","year":"2002","journal-title":"Cancer Res."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1096\/fasebj.11.6.9194527","article-title":"Expression of the Mel1a-melatonin receptor mRNA in T and B subsets of lymphocytes from rat thymus and spleen","volume":"11","author":"Pozo","year":"1997","journal-title":"FASEB J."},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3816\/CLC.2004.n.021","article-title":"Angiogenesis inhibitors: A rational strategy for radiosensitization in the treatment of non-small-cell lung cancer?","volume":"6","author":"Raben","year":"2004","journal-title":"Clin. Lung Cancer"},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1038\/sj.bjc.6603935","article-title":"Inhibitory effects of pharmacological doses of melatonin on aromatase activity and expression in rat glioma cells","volume":"97","author":"Mediavilla","year":"2007","journal-title":"Br. J. Cancer"},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0165-5728(98)00268-9","article-title":"Characterization of membrane melatonin receptor in mouse peritoneal macrophages: Inhibition of adenylyl cyclase by a pertussis toxin-sensitive G protein","volume":"95","author":"Guerrero","year":"1999","journal-title":"J. Neuroimmunol."},{"key":"ref_95","first-page":"103","article-title":"Effects of NF-kappaB1 (p50) targeted gene disruption on ionizing radiation-induced NF-kappaB activation and TNFalpha, IL-1alpha, IL-1beta and IL-6 mRNA expression in vivo","volume":"298","author":"Zhou","year":"2001","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"43","DOI":"10.2119\/molmed.2008.00117","article-title":"Melatonin: An established antioxidant worthy of use in clinical trials","volume":"15","author":"Korkmaz","year":"2009","journal-title":"Mol. Med."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s00204-015-1459-z","article-title":"The role of DNA damage responses in p53 biology","volume":"89","author":"Speidel","year":"2015","journal-title":"Arch. Toxicol."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"710","DOI":"10.4161\/cc.28108","article-title":"Revisiting p53 for cancer-specific chemo- and radiotherapy: Ten years after","volume":"13","author":"Beckta","year":"2014","journal-title":"Cell Cycle"},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"17081","DOI":"10.18632\/oncotarget.4012","article-title":"Melatonin antiproliferative effects require active mitochondrial function in embryonal carcinoma cells","volume":"6","author":"Loureiro","year":"2015","journal-title":"Oncotarget"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.1073\/pnas.93.8.3636","article-title":"Amplification of AKT2 in human pancreatic cells and inhibition of AKT2 expression and tumorigenicity by antisense RNA","volume":"93","author":"Cheng","year":"1996","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/ijc.2910640412","article-title":"Molecular alterations of the AKT2 oncogene in ovarian and breast carcinomas","volume":"64","author":"Bellacosa","year":"1995","journal-title":"Int. J. Cancer"},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1093\/carcin\/23.1.201","article-title":"AKT proto-oncogene overexpression is an early event during sporadic colon carcinogenesis","volume":"23","author":"Roy","year":"2002","journal-title":"Carcinogenesis"},{"key":"ref_103","first-page":"25","article-title":"Akt2 expression correlates with prognosis of human hepatocellular carcinoma","volume":"11","author":"Xu","year":"2004","journal-title":"Oncol. Rep."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.3892\/ol.2012.928","article-title":"Energy metabolism of cancer: Glycolysis versus oxidative phosphorylation (Review)","volume":"4","author":"Zheng","year":"2012","journal-title":"Oncol. Lett."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"3430","DOI":"10.7150\/jca.21125","article-title":"The glycolytic switch in tumors: How many players are involved?","volume":"8","author":"Yu","year":"2017","journal-title":"J. Cancer"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/j.radonc.2014.07.015","article-title":"AKT-mediated enhanced aerobic glycolysis causes acquired radioresistance by human tumor cells","volume":"112","author":"Shimura","year":"2014","journal-title":"Radiother. Oncol."},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"4996","DOI":"10.1038\/onc.2012.13","article-title":"Switching from aerobic glycolysis to oxidative phosphorylation modulates the sensitivity of mantle cell lymphoma cells to TRAIL","volume":"31","author":"Robinson","year":"2012","journal-title":"Oncogene"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000227533","article-title":"Increased survival time in brain glioblastomas by a radioneuroendocrine strategy with radiotherapy plus melatonin compared to radiotherapy alone","volume":"53","author":"Lissoni","year":"1996","journal-title":"Oncology"},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.ijrobp.2007.01.012","article-title":"Randomized phase II trial of high dose melatonin and radiation therapy for RPA class 2 patients with brain metastases (RTOG 0119)","volume":"68","author":"Berk","year":"2007","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_110","first-page":"188","article-title":"Melatonin for prevention of breast radiation dermatitis: A phase II, prospective, double-blind randomized trial","volume":"18","author":"Elkayam","year":"2016","journal-title":"Isr. Med. Assoc. J."},{"key":"ref_111","first-page":"397","article-title":"A study of immunoendocrine strategies with pineal indoles and interleukin-2 to prevent radiotherapy-induced lymphocytopenia in cancer patients","volume":"22","author":"Lissoni","year":"2008","journal-title":"In Vivo"},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1177\/1534735411425484","article-title":"Melatonin as adjuvant cancer care with and without chemotherapy: A systematic review and meta-analysis of randomized trials","volume":"11","author":"Seely","year":"2012","journal-title":"Integr. Cancer Ther."}],"container-title":["Biomedicines"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2227-9059\/8\/8\/247\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T09:51:54Z","timestamp":1760176314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2227-9059\/8\/8\/247"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,7,27]]},"references-count":112,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2020,8]]}},"alternative-id":["biomedicines8080247"],"URL":"https:\/\/doi.org\/10.3390\/biomedicines8080247","relation":{},"ISSN":["2227-9059"],"issn-type":[{"value":"2227-9059","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,7,27]]}}}